AASLD

We are seeking an AASLD member to serve as invited faculty at the Hong Kong Association for the Study of Liver Diseases (HKASLD) 39th Annual Scientific Meeting.

The selected participant will earn a $1,000 honorarium and travel support to present original research, serve as a session moderator, and mentor HKASLD trainees.

Eligible applicants include early-career academic hepatologists who are AASLD members in good standing and within five years of their first faculty appointments at a North American institution.

View the full eligibility criteria and apply by August 10. https://bit.ly/4pe9asQ

Learn on-the-go as we collaborate with ISDA, ALEH, and API during a webinar on Viral Hepatitis in Latin America on World Hepatitis Day at 7 p.m. EDT! Held in Spanish with English subtitles, join AASLD/IDSA member Harrys Torres, MD, FAASLD, and ALEH member Ezequiel Ridruejo, MD, PhD as they discuss and .

Prepare for the in-depth conversation on vaccination, diagnosis, and treatment approaches that lead to a roundtable on current efforts of viral hepatitis elimination. Register now at https://bit.ly/4aInYtV.

A 62-year-old man with compensated HCV cirrhosis is found to have two LI-RADS 5 lesions on HCC surveillance, with no vascular invasion or extrahepatic spread.

What is the best treatment option?
A) Surgical resection
B) Systemic therapy with atezolizumab-bevacizumab
C) Locoregional therapy to downstage
D) TACE followed by systemic therapy with atezolizumab-bevacizumab

[These questions are created by transplant hepatology fellows with faculty oversight, and are intended to help solidify core concepts within general and advanced hepatology.]

We join the liver community in honoring the life and legacy of Thelma King Thiel.

After losing her son Dean to in 1970, she transformed unimaginable grief into a lifetime of advocacy. Known as "The Liver Lady," she helped raise national awareness of , championed prevention, and inspired generations to protect .

Her impact will continue to shape the future of liver care for years to come.